Rabeprazole Sandoz

Rabeprazole Sandoz Warnings

rabeprazole

Manufacturer:

Sandoz

Distributor:

Zuellig
Full Prescribing Info
Warnings
Hypomagnesemia, symptomatic and asymptomatic, has been reported rarely in patients treated with proton-pump inhibitors for at least 3 months, in most cases after a year of therapy. Serious adverse events include tetany, arrhythmias and seizures. In most patients, treatment of hypomagnesemia required magnesium replacement and discontinuation of the proton-pump inhibitors. For patients expected to be on prolonged treatment or who take proton-pump inhibitors with medications eg, digoxin or drugs that may cause hypomagnesemia (eg, diuretics), healthcare professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in